search
Back to results

Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy

Primary Purpose

Hypoxic Ischemic Encephalopathy, Perinatal Asphyxia

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Ascorbic acid (vitamin C)
Ibuprofen
Placebo
Sponsored by
Al-Azhar University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypoxic Ischemic Encephalopathy focused on measuring Interleukin 1-beta, Interleukin 6, Vitamin C, HIE, neonates

Eligibility Criteria

undefined - 2 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Apgar score at 5 minutes < 6
  • Profound metabolic or mixed acidosis with pH < 7 in the initial blood gas
  • Evidence of encephalopathy such as coma, seizures or hypotonia
  • Evidence of multi-system compromise, in addition to encephalopathy

Exclusion Criteria:

  • Major congenital anomalies
  • Early sepsis
  • Gastrointestinal bleeding
  • Thrombocytopenia

Sites / Locations

  • Bab El-Shariya Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

A

B

Arm Description

Infants will receive intravenous ascorbic acid and oral ibuprofen for 3 days

Infants will receive equivalent amount of placebo

Outcomes

Primary Outcome Measures

DDST-II
Neurological Examination

Secondary Outcome Measures

Death
Neurological Examination

Full Information

First Posted
February 20, 2008
Last Updated
February 27, 2008
Sponsor
Al-Azhar University
search

1. Study Identification

Unique Protocol Identification Number
NCT00624871
Brief Title
Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy
Official Title
Ascorbic Acid Combined With Ibuprofen in Hypoxic Ischemic Encephalopathy: A Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2008
Overall Recruitment Status
Completed
Study Start Date
April 2004 (undefined)
Primary Completion Date
April 2006 (Actual)
Study Completion Date
April 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Al-Azhar University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Oxygen radicals and inflammation are important causes for brain injury in neonates following perinatal asphyxia. Animal studies demonstrated potential benefits to the brain when using both of vitamin C and ibuprofen. The efficacy of these 2 drugs when combined in protecting the human brain has not been studied. We aimed in this study to test the hypothesis that a combination of anti-oxidants (vitamin C) and anti-inflammatory (ibuprofen) drugs can decrease the brain injury in perinatal asphyxia and improve outcomes when given to infants immediately after birth.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypoxic Ischemic Encephalopathy, Perinatal Asphyxia
Keywords
Interleukin 1-beta, Interleukin 6, Vitamin C, HIE, neonates

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Active Comparator
Arm Description
Infants will receive intravenous ascorbic acid and oral ibuprofen for 3 days
Arm Title
B
Arm Type
Placebo Comparator
Arm Description
Infants will receive equivalent amount of placebo
Intervention Type
Drug
Intervention Name(s)
Ascorbic acid (vitamin C)
Intervention Description
IV, 100 mg/kg/day, every day, for 3 days
Intervention Type
Drug
Intervention Name(s)
Ibuprofen
Intervention Description
PO, 10 mg/kg on day 1, 5 mg/kg/day on days 2 and 3 of life
Intervention Type
Drug
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
DDST-II
Time Frame
6 months
Title
Neurological Examination
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Death
Time Frame
On Discharge
Title
Neurological Examination
Time Frame
On Discharge

10. Eligibility

Sex
All
Maximum Age & Unit of Time
2 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Apgar score at 5 minutes < 6 Profound metabolic or mixed acidosis with pH < 7 in the initial blood gas Evidence of encephalopathy such as coma, seizures or hypotonia Evidence of multi-system compromise, in addition to encephalopathy Exclusion Criteria: Major congenital anomalies Early sepsis Gastrointestinal bleeding Thrombocytopenia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmed Elsayed, MD
Organizational Affiliation
Al-Azhar University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Laila Abd-Rabboh, MD
Organizational Affiliation
Al-Azhar University
Official's Role
Study Chair
Facility Information:
Facility Name
Bab El-Shariya Hospital
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy

We'll reach out to this number within 24 hrs